We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer.
- Authors
Yang, Jin-Ji; Fang, Jian; Shu, Yong-Qian; Chang, Jian-Hua; Chen, Gong-Yan; He, Jian Xing; Li, Wei; Liu, Xiao-Qing; Yang, Nong; Zhou, Caicun; Huang, Jian An; Frigault, Melanie M.; Hartmaier, Ryan; Ahmed, Ghada F.; Egile, Coumaran; Morgan, Shethah; Verheijen, Remy B.; Mellemgaard, Anders; Yang, Liu; Wu, Yi-Long
- Publication
Investigational New Drugs, 2021, Vol 39, Issue 2, p477
- ISSN
0167-6997
- Publication type
Article
- DOI
10.1007/s10637-020-01010-4